Clinical Trial Update: Proof of Concept and Dose-ranging Study of INDV-2000 in Individuals With Moderate to Severe Opioid Use Disorder [Phase 2]

View source ↗

Summary

INDV-2000, an investigational treatment from Indivior, completed a Phase 2 proof-of-concept and dose-ranging study in adults with moderate to severe opioid use …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• INDV-2000

Snippet

Sponsor: Indivior Inc. | Conditions: Opioid Use Disorder | Phase 2 | Status: COMPLETED